Maya L Chan1, John A Spertus2, Fengming Tang3, Natalie Jayaram4, Paul S Chan5. 1. Pembroke Hill High School, Kansas City, MO. 2. Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. 3. Saint Luke's Mid America Heart Institute, Kansas City, MO. 4. University of Missouri-Kansas City, Kansas City, MO; Childrens's Mercy Hospital, Kansas City, MO. 5. Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. Electronic address: pchan@saint-lukes.org.
Abstract
BACKGROUND: Hospitals often employ Medical Emergency Teams (METs) to respond to patients with acute physiological decline so as to prevent deaths from in-hospital cardiac arrest (IHCA). We determined the frequency of missed opportunities for MET evaluation, defined as no MET evaluation prior to IHCA despite evidence of severe vital sign abnormalities ≥1 hour preceding cardiac arrest. METHODS: Within Get With The Guidelines-Resuscitation, we identified 21,913 patients from 274 hospitals with IHCA on general inpatient or telemetry floors who would be eligible for a MET evaluation prior to IHCA. We determined the proportion of patients with missed opportunities for MET evaluation, defined as no MET evaluation before IHCA despite at least 1 severe vital sign abnormality (pulse >150 or <30, respiratory rate >35 or <8, systolic blood pressure <80, and oxygen saturation <80%) 1, 2, and 4 hours before IHCA. The relationship between a hospital's proportion of missed opportunities for MET evaluation and its risk-standardized rate of survival to discharge for IHCA (derived using hierarchical linear regression models) was then evaluated. RESULTS: Overall, few (3,814 [17.4%]) patients with IHCA had a preceding MET evaluation, and the odds of a MET evaluation varied by >80% across hospitals (median, 14.6% [interquartile range, 9.1%-22.2%]; median odds ratio, 1.82). Vital sign data were available for 13,115 (72.5%) of the 18,099 patients without MET evaluation. Of these patients, 5,243 (40.0%), 4,078 (31.1%), and 1,767 (13.4%) had at least 1 severe vital sign abnormality ≥1, 2, and 4 hours before IHCA, respectively. Hospitals with the highest proportion of unevaluated patients despite severe vital sign abnormalities 2 and 4 hours preceding cardiac arrest had the lowest IHCA survival rate (correlation of -0.14 [P = .04] and -0.16 [P = .01], respectively). CONCLUSIONS: Although METs are designed to prevent IHCA, many patients with severe vital sign abnormalities prior to IHCA did not have a MET evaluation, and hospitals with higher rates of unevaluated patients had lower IHCA survival. These findings suggest missed opportunities to efficiently use METs in current practice.
BACKGROUND: Hospitals often employ Medical Emergency Teams (METs) to respond to patients with acute physiological decline so as to prevent deaths from in-hospital cardiac arrest (IHCA). We determined the frequency of missed opportunities for MET evaluation, defined as no MET evaluation prior to IHCA despite evidence of severe vital sign abnormalities ≥1 hour preceding cardiac arrest. METHODS: Within Get With The Guidelines-Resuscitation, we identified 21,913 patients from 274 hospitals with IHCA on general inpatient or telemetry floors who would be eligible for a MET evaluation prior to IHCA. We determined the proportion of patients with missed opportunities for MET evaluation, defined as no MET evaluation before IHCA despite at least 1 severe vital sign abnormality (pulse >150 or <30, respiratory rate >35 or <8, systolic blood pressure <80, and oxygen saturation <80%) 1, 2, and 4 hours before IHCA. The relationship between a hospital's proportion of missed opportunities for MET evaluation and its risk-standardized rate of survival to discharge for IHCA (derived using hierarchical linear regression models) was then evaluated. RESULTS: Overall, few (3,814 [17.4%]) patients with IHCA had a preceding MET evaluation, and the odds of a MET evaluation varied by >80% across hospitals (median, 14.6% [interquartile range, 9.1%-22.2%]; median odds ratio, 1.82). Vital sign data were available for 13,115 (72.5%) of the 18,099 patients without MET evaluation. Of these patients, 5,243 (40.0%), 4,078 (31.1%), and 1,767 (13.4%) had at least 1 severe vital sign abnormality ≥1, 2, and 4 hours before IHCA, respectively. Hospitals with the highest proportion of unevaluated patients despite severe vital sign abnormalities 2 and 4 hours preceding cardiac arrest had the lowest IHCA survival rate (correlation of -0.14 [P = .04] and -0.16 [P = .01], respectively). CONCLUSIONS: Although METs are designed to prevent IHCA, many patients with severe vital sign abnormalities prior to IHCA did not have a MET evaluation, and hospitals with higher rates of unevaluated patients had lower IHCA survival. These findings suggest missed opportunities to efficiently use METs in current practice.
Authors: Michael A Devita; Rinaldo Bellomo; Kenneth Hillman; John Kellum; Armando Rotondi; Dan Teres; Andrew Auerbach; Wen-Jon Chen; Kathy Duncan; Gary Kenward; Max Bell; Michael Buist; Jack Chen; Julian Bion; Ann Kirby; Geoff Lighthall; John Ovreveit; R Scott Braithwaite; John Gosbee; Eric Milbrandt; Mimi Peberdy; Lucy Savitz; Lis Young; Maurene Harvey; Sanjay Galhotra Journal: Crit Care Med Date: 2006-09 Impact factor: 7.598
Authors: R O Cummins; D Chamberlain; M F Hazinski; V Nadkarni; W Kloeck; E Kramer; L Becker; C Robertson; R Koster; A Zaritsky; L Bossaert; J P Ornato; V Callanan; M Allen; P Steen; B Connolly; A Sanders; A Idris; S Cobbe Journal: Circulation Date: 1997-04-15 Impact factor: 29.690
Authors: Paul S Chan; Adnan Khalid; Lance S Longmore; Robert A Berg; Mikhail Kosiborod; John A Spertus Journal: JAMA Date: 2008-12-03 Impact factor: 56.272
Authors: Paul S Chan; Robert A Berg; John A Spertus; Lee H Schwamm; Deepak L Bhatt; Gregg C Fonarow; Paul A Heidenreich; Brahmajee K Nallamothu; Fengming Tang; Raina M Merchant Journal: J Am Coll Cardiol Date: 2013-06-13 Impact factor: 24.094
Authors: Mary Ann Peberdy; William Kaye; Joseph P Ornato; Gregory L Larkin; Vinay Nadkarni; Mary Elizabeth Mancini; Robert A Berg; Graham Nichol; Tanya Lane-Trultt Journal: Resuscitation Date: 2003-09 Impact factor: 5.262
Authors: Shelby Kutty; Philip G Jones; Quentin Karels; Navya Joseph; John A Spertus; Paul S Chan Journal: Circulation Date: 2017-10-04 Impact factor: 29.690